Treatment of Rheumatoid Hand With Magnetotherapy

Sponsor
Jolanta Zwolińska (Other)
Overall Status
Completed
CT.gov ID
NCT05920746
Collaborator
(none)
72
1
2
22.2
3.2

Study Details

Study Description

Brief Summary

Brief Summary:

Participants with rheumatoid arthritis with recommendation to physiotherapy.

Created 2 study groups:
  1. Kinesiotherapy with static magnetic field

  2. Kinesiotherapy with low-frequency pulsed magnetic field

Pulsed magnetic field give better effects then static magnetic field.

Condition or Disease Intervention/Treatment Phase
  • Other: Kinesiotherapy with magnetotherapy
N/A

Detailed Description

Participants with rheumatoid arthritis with recommendation to physiotherapy. All participants have dysfunction and pain of hand.

Inclusion criteria:
  1. Informed voluntary consent to participate in the study

  2. II ° and III ° of advancement of radiological changes

  3. II ° and III ° of advancement of functional changes

  4. Remission, low or moderate RA activity: DAS28

  5. Medical referral for physiotherapy treatment

Exclusion criteria:
  1. Additional physiotherapy treatments for the hands

  2. Contraindications for magnetotherapy treatments

  3. Lack of informed, voluntary consent to participate in the study

Outcome Measures:
  1. Duration of morning stiffness

  2. The degree of severity of morning stiffness

  3. Pain intensity assessment (VAS)

  4. Measuring the range of motion in the joints of the hand

  5. Hand volume measurement

  6. HAQ-20 test

Intervention:
  1. Group "S": Kinesiotherapy with static magnetic field

  2. Group "P": Kinesiotherapy with low-frequency pulsed magnetic field

Assessment:
  1. Immediately before start therapy

  2. Immediately after therapy (10 treatments in 3 weeks)

Study Design

Study Type:
Interventional
Actual Enrollment :
72 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
Assessor evaluating the patients' condition had no knowledge of the outcome of randomization of patients to the study groups.
Primary Purpose:
Treatment
Official Title:
Type of Magnetic Field and the Effects of Rheumatoid Arthritis Treatment
Actual Study Start Date :
Mar 1, 2021
Actual Primary Completion Date :
Nov 1, 2022
Actual Study Completion Date :
Jan 5, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Kinesiotherapy with Static Magnetic Field

Patients have kinesiotherapy of hand and static magnetic field. All patients without steroid anti-inflammatory drugs.

Other: Kinesiotherapy with magnetotherapy
Individual kinesiotherapy. Parameters of magnetic field: 7 mT, f= 10-20 Hz, type of impulse: bipolar, rectangular pulse
Other Names:
  • Kinesiotherapy with static magnetic field
  • Kinesiotherapy with low-frequency pulsed magnetic field
  • Experimental: Kinesiotherapy with low-frequency pulsed magnetic field

    Patients have kinesiotherapy of hand and low-frequency pulsed magnetic field. All patients without steroid anti-inflammatory drugs.

    Other: Kinesiotherapy with magnetotherapy
    Individual kinesiotherapy. Parameters of magnetic field: 7 mT, f= 10-20 Hz, type of impulse: bipolar, rectangular pulse
    Other Names:
  • Kinesiotherapy with static magnetic field
  • Kinesiotherapy with low-frequency pulsed magnetic field
  • Outcome Measures

    Primary Outcome Measures

    1. Visual Analogue Scale (VAS) [Change from baseline VAS value immediately after therapy.]

      Pain severity rating scale. only one value. Minimum value is 0, maximum value is 10. The best is 0, the worst is 10.

    2. Health Assesment Questionaire (HAQ-20) [Change from baseline HAQ-20 value immediately after therapy.]

      Subjective assesment of level of disability. Value of each of 8 subsections: minimum value 0, maximum value 3. total score is averaged. The best total score is 0, the worst is 3

    3. Range of motion [Change from baseline range of motion value immediately after therapy.]

      Computerized measurement of the range of motion of the joints of the hand [mm].

    4. Displacement hand volume measurement [Change from baseline volume value immediately after therapy.]

      Measurement of hand volume using the displacement method [mm3].

    5. Persistence time of morning stiffness [Change from baseline time of morning stiffness value immediately after therapy.]

      Patient's subjective assessment of the duration of morning stiffness [min].

    6. Severity of morning stiffness [Change from baseline time of severity of morning stiffness value immediately after therapy.]

      Assessing the severity of morning stiffness using a 100-point scale.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    35 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Informed voluntary consent to participate in the study

    2. II ° and III ° of advancement of radiological changes

    3. II ° and III ° of advancement of functional changes

    4. Remission, low or moderate RA activity: DAS28

    5. Medical referral for physiotherapy treatment

    Exclusion Criteria:
    1. Additional physiotherapy treatments for the hands

    2. Contraindications for magnetotherapy treatments

    3. Lack of informed, voluntary consent to participate in the study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Laboratorium Czynników Fizykalnych w Rehabilitacji w Przyrodniczo-Medycznym Centrum Badań Innowacyjnych Uniwersytetu Rzeszowskiego Rzeszów Podkarpackie Poland 35-310 Rzeszów

    Sponsors and Collaborators

    • Jolanta Zwolińska

    Investigators

    • Principal Investigator: Jolanta Zwolinska, PhD, University of Rzeszow

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Jolanta Zwolińska, PhD, University of Rzeszow
    ClinicalTrials.gov Identifier:
    NCT05920746
    Other Study ID Numbers:
    • Universyty of Rzeszow
    First Posted:
    Jun 27, 2023
    Last Update Posted:
    Jun 27, 2023
    Last Verified:
    Jun 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Jolanta Zwolińska, PhD, University of Rzeszow
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 27, 2023